Establishment Labs Holdings Inc Stock
Heavy losses for Establishment Labs Holdings Inc today as the stock fell by -€2.400 (-5.260%).
With 9 Buy predictions and not the single Sell prediction the community is currently very high on Establishment Labs Holdings Inc.
As a result the target price of 55 € shows a positive potential of 27.31% compared to the current price of 43.2 € for Establishment Labs Holdings Inc.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Establishment Labs Holdings Inc stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Establishment Labs Holdings Inc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Cons
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Comments
Establishment Labs Holdings Inc. (NASDAQ: ESTA) had its price target raised by analysts at Citigroup Inc. from $49.00 to $60.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ESTA provided by MarketBeat
Establishment Labs Holdings Inc. (NASDAQ: ESTA) had its price target raised by analysts at Mizuho from $50.00 to $65.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ESTA provided by MarketBeat
Establishment Labs Holdings Inc. (NASDAQ: ESTA) had its price target raised by analysts at JPMorgan Chase & Co. from $46.00 to $53.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for ESTA provided by MarketBeat
News
Establishment Labs to Announce First Quarter 2024 Financial Results on May 8
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans
Establishment Labs Announces Participation in The Aesthetic Meeting 2024
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today
Establishment Labs Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today